ROME, June 11 (Reuters) - The Italian government said on Friday it was restricting the use of the AstraZeneca COVID-19 vaccine to people over the age of 60, after a teenager who had received the shot died from a rare form of blood clotting.
Camilla Canepa died on Thursday aged 18 after being given the vaccine on May 25, triggering a media and political outcry over the Anglo-Swedish company's shot being used for adults of all ages despite previously-raised medical concerns.